CHIROSCIENCE LEVOBUPIVACAINE NDA FILING SET FOR EARLY 1998, SEPRACOR R-ALBUTEROL IN 1997; FDA CONSIDERING "SHIFT IN EXPECTATION" FOR SINGLE ISOMER DEVELOPMENT
Executive Summary
Chiroscience anticipates a first quarter 1998 NDA filing for levobupivacaine, a single isomer of bupivacaine, Chiroscience Medical Director Brian Gennery, MD, said Jan. 14 at a conference on stereoisomers sponsored by Georgetown University's Center for Drug Development Science.